Navigation Links
Glufast in Medical Technology

Elixir Pharmaceuticals Announces Clinical Data at American Diabetes Association Conference Highlighting Ability of Glufast to Maintain Glycemic Control in Patients with Type 2 Diabetes

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - Elixir Pharmaceuticals, Inc., announced today the publication of clinical data highlighting the ability of Glufast(R) (mitiglinide calcium hydrate) monotherapy, or combination therapy with metformin, to manage glucose surges before and after meals. ...

Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control

...te), an insulin secretagogue, which lowers post-meal glucose levels by improving the body's own ability to produce insulin. Already marketed in Japan, glufast has undergone extensive clinical development demonstrating the product's ability to safely and effectively treat Type 2 diabetes. Elixir has also de...

Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Association's Annual Meeting

...te), an insulin secretagogue, which lowers post-meal glucose levels by improving the body's own ability to produce insulin. Already marketed in Japan, glufast has undergone extensive clinical development demonstrating the product's ability to safely and effectively treat Type 2 diabetes. Elixir has also de...
Glufast in other areas

Welcome to glufast.com

glufast.com ... glufast.com Registered Contact Owner ...

Elixir Pharmaceuticals Acquires Late-Stage Product for the Treatment of ...

to develop and commercialize Glufast(R) (mitiglinide calcium hydrate) in ... Currently marketed in Japan, Glufast is an insulin secretagogue that ... Glufast ...

Elixir Pharmaceuticals Announces Clinical Data at American Diabetes ...

"The publication of these data provide compelling confirmatory evidence that Glufast can control ... Glufast both as a single agent and in combination with ...

Elixir Pharmaceuticals Acquires Late-Stage Product for the

exclusive right to develop and commercialize Glufast(R) (mitiglinide calcium hydrate) in ... Currently marketed in Japan, Glufast is an ...

The FINANCIAL - Approval of an Additional Indication of Combination ...

The FINANCIAL, news flash, Pharmacy, Approval of an Additional Indication of Combination Therapy of Glufast and Insulin Sensitizer in Jap

Glufast On Insulin Glargine Trial in Type 2 DM - Full Text View ...

Glufast On Insulin Glargine Trial in Type 2 DM (GLORIA) ... We will evaluate the efficacy and safety of combination therapy of 10 mg ...
Other Tags
(Date:3/3/2015)... New York, New York (PRWEB) March 03, 2015 ... that question tactics used to market the atypical ... around the U.S. According to court documents, the ... jury’s 2011 finding that Johnson & Johnson’s Janssen ... concealed its serious risks. However, while the Court’s ...
(Date:3/3/2015)... Loma Linda University Health announced today, ... being, it will be offering new, healthier choices in ... Over the past year, a cross-section of Loma Linda ... criteria, listening to vendors, sampling their products, and ultimately ... , Most recently, a food fair was held during ...
(Date:3/3/2015)... Today, Steve Weatherford, current New York Giants ... announced the donation of their brains to science during ... Month. In an effort to raise awareness for the ... health, Rice and Weatherford spoke of their experiences on ... brain health a priority to avoid the consequences of ...
(Date:3/3/2015)... March 03, 2015 Man, Woman & ... to help find cures and ensure access to treatments ... life for patents and their families. Through this annual ... in the fight for a world without blood cancers. ... fundraisers in the country, to be announced this summer. ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles ... crimes, recently spoke on the radio to give his insights ... the Independent Journal Review radio show “The Right Mics” chose ... prosecutor and now as a criminal defense attorney would provide ... trial and sentencing of this high-profile case. , During the ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/10/2015)...  Alere Inc. (NYSE: ALR), a global leader ... the quarter ended December 31, 2014. ... Alere said, "We made substantial progress in the ... leader in rapid diagnostics and delivering against our ... in early January enabled us to substantially reduce ...
(Date:2/5/2015)... Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... ( http://www.nxt-id.com/ ) as part of its 2015 marketing ... Company launched its new consumer website for Wocketwallet.com earlier ... CEO of NXT-ID said, "Our new corporate website naturally ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
Other Contents